Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

What Is the Growth Rate of the Open-Angle Glaucoma (OAG) Market?

The market for open-angle glaucoma (OAG) has been showing robust growth in recent years. The current market worth of $6.13 billion in 2024 is expected to increase to $6.55 billion in 2025, representing a compound annual growth rate (CAGR) of 6.8%. Factors contributing to this growth during the historical period include a higher occurrence rate of glaucoma in aging demographics, increased consciousness about early screening for eye diseases, escalated healthcare spending, government-led vision care programs, and the worldwide growth of ophthalmology practices.

What Growth Rate Is Forecasted for the Open-Angle Glaucoma (OAG) Market by 2029?

Strong expansion is anticipated in the open-angle glaucoma (OAG) market over the coming years, with the size predicted to reach $8.42 billion in 2029, boasting a compound annual growth rate (CAGR) of 6.5%. This growth during the prediction period can be associated with growing demands for combination therapies and a heightened interest in personalized medicine. It can also be attributed to refined reimbursement policies for glaucoma treatments, augmented incidence of lifestyle-related eye conditions, and an escalating demand for non-invasive diagnostic methods. The predicted period also sees key trends such as increased employment of AI in glaucoma diagnostics, a move towards outpatient glaucoma surgical procedures, a growing utilization of sustained-release glaucoma implants, increased incorporation of wearable technology for tracking intraocular pressure, and an enhanced focus on sustainability in the production of medical devices.

Download The Free Sample Report Here:

https://www.thebusinessresearchcompany.com/sample.aspx?id=20911&type=smp

Which Key Companies Are Shaping the Future of the Open-Angle Glaucoma (OAG) Market?

Major companies operating in the open-angle glaucoma (OAG) market are Pfizer Inc., Merck & Co. Inc., AbbVie Inc, Novartis AG, Amgen Inc., Teva Pharmaceutical Industries Ltd., Boston Scientific, Alcon Inc., Bausch Health Companies Inc., Hoya Corporation, Sun Pharmaceutical Industries Ltd., Santen Pharmaceuticals, Mallinckrodt Pharmaceuticals, Théa Pharma, Glaukos Corporation, Quantel Medical, EyePoint Pharmaceuticals Inc., iSTAR Medical, Nicox Ophthalmics, Visus Therapeutics, Peregrine Eye Laser and Institute, Inotek Pharmaceuticals

Which Factors Are Driving Demand in the Open-Angle Glaucoma (OAG) Industry?

As people become more conscious of eye diseases, it is anticipated that this will stimulate growth in the open-angle glaucoma (OAG) market. Eye diseases refer to a broad spectrum of conditions affecting the eyes’ structure, functionality, or vision, spanning from trivial issues like dry eye to severe ailments such as glaucoma and macular degeneration. Factors such as an aging demographic, extended screen time, rising diabetes cases, environmental pollution, and lifestyle practices that stress eye health contribute to an increase in their occurrence. Open-angle glaucoma (OAG), a main cause of blindness primarily in the elderly, emphasizes the essentiality of regular eye check-ups, early detection, and aggressive treatment to avoid irreversible vision impairment. For example, the Royal National Institute of Blind People (RNIB), a sight loss charity located in the UK, reported in October 2023 that the number of eye care outpatient visits in the UK surpassed eight million in 2021/22, making it the most sought-after specialty. In addition, it is anticipated that the current figure of over two million people suffering from sight loss will likely double to more than four million by 2050. As such, the escalating consciousness about eye diseases is facilitating growth in the open-angle glaucoma (OAG) market.

Request For A Customized Report:

https://www.thebusinessresearchcompany.com/customise?id=20911&type=smp

How Is the Open-Angle Glaucoma (OAG) Market Segmented by Several Divisions?

The open-angle glaucoma (OAG) market covered in this report is segmented –

1) By Disease Type: Open Angle Glaucoma, Angle Closure Glaucoma, Other Disease Type

2) By Drug Class: Prostaglandin Analog, Beta Blockers, Adrenergic Agonist, Carbonic Anhydrase Inhibitors, Others Drug Class

3) By End User: Hospitals, Homecare, Specialty Clinics, Other End Users

4) By Distribution Channel: Hospital Pharmacy, Online Pharmacy, Retail Pharmacy

Subsegments:

1) By Open Angle Glaucoma (OAG): Primary Open-Angle Glaucoma (POAG), Secondary Open-Angle Glaucoma

2) By Angle Closure Glaucoma: Acute Angle-Closure Glaucoma, Chronic Angle-Closure Glaucoma

3) By Other Disease Type: Normal-Tension Glaucoma, Congenital Glaucoma, Secondary Glaucoma

What are the Emerging Market Trends Driving the Growth of the Open-Angle Glaucoma (OAG) Industry?

Top-rated companies in the open-angle glaucoma (OAG) market are focusing on the creation of innovative solutions, such as minimally invasive glaucoma devices (MIGDs), to offer cutting-edge, less invasive options for managing primary open-angle glaucoma, moving away from traditional treatment methods. A minimally invasive glaucoma device (MIGD) is a variety of surgical implants and methods developed to reduce intraocular pressure in patients with glaucoma via tiny incisions and minimal disruption to ocular tissues. For example, in December 2023, MINIject was launched in the Netherlands by iSTAR Medical, a Belgium-based medical technology company. This integrated treatment for primary open-angle glaucoma uses porous STAR material to improve fluid outflow and lower IOP. MINIject marks a considerable advancement in glaucoma treatment by providing a safer and more effective management method for this main reason for irreversible blindness, reducing reliance on traditional therapies.

Access The Full Report Here:

https://www.thebusinessresearchcompany.com/report/open-angle-glaucoma-oag-global-market-report

Which Regions Are Driving Growth in the Open-Angle Glaucoma (OAG) Market?

North America was the largest region in the open-angle glaucoma (OAG) market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the open-angle glaucoma (OAG) market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Purchase The Full Report Today:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=20911

This Report Delivers Insight On:

1. How big is the open-angle glaucoma (oag) market, and how is it changing globally?

2. Who are the major companies in the open-angle glaucoma (oag) market, and how are they performing?

3. What are the key opportunities and risks in the open-angle glaucoma (oag) market right now?

4. Which products or customer segments are growing the most in the open-angle glaucoma (oag) market?

5. What factors are helping or slowing down the growth of the open-angle glaucoma (oag) market?

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Europe +44 7882 955267

Asia & Others +44 7882 955267 & +91 8897263534

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model